Colgate-Palmolive (NYSE:CL) Shares Sold by Bank of New Hampshire

Bank of New Hampshire trimmed its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 6.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,212 shares of the company’s stock after selling 536 shares during the period. Bank of New Hampshire’s holdings in Colgate-Palmolive were worth $676,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $27,000. Vermillion Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $31,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $32,000. Finally, Briaud Financial Planning Inc acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CL shares. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an “overweight” rating in a research report on Monday, April 28th. UBS Group upped their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the company a “buy” rating in a research report on Thursday, April 17th. Citigroup upped their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a “buy” rating in a research report on Monday, April 28th. Piper Sandler dropped their price target on Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating on the stock in a research report on Monday, March 31st. Finally, Wells Fargo & Company upped their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a research report on Wednesday, April 2nd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $102.12.

View Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $90.18 on Friday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The business’s fifty day moving average price is $91.77 and its two-hundred day moving average price is $91.17. The firm has a market capitalization of $73.08 billion, a PE ratio of 25.62, a P/E/G ratio of 4.20 and a beta of 0.38.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period last year, the company earned $0.86 earnings per share. The firm’s revenue for the quarter was down 3.0% on a year-over-year basis. On average, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its board has initiated a stock buyback program on Thursday, March 20th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to buy up to 6.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were paid a $0.52 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date was Thursday, April 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is presently 58.76%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.